» Articles » PMID: 28848549

Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?

Overview
Journal Front Immunol
Date 2017 Aug 30
PMID 28848549
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a prevalent chronic heterogeneous inflammatory disease of the airways, leading to reversible airway obstruction, in which various inflammatory responses can be observed. Mild to moderate asthma patients often present with a Th2-mediated eosinophilic inflammation whereas in severe asthma patients, a Th17-associated neutrophilic or combined Th2 and Th17-mediated eosinophilic/neutrophilic inflammation is observed. The differentiation of these effector Th2 and Th17-cells is induced by allergen-exposed dendritic cells (DCs) that migrate toward the lung draining lymph node. The DC lineage comprises conventional DCs (cDCs) and plasmacytoid DCs (pDCs), of which the cDC lineage consists of type 1 cDCs (cDC1s) and cDC2s. During inflammation, also monocytes can differentiate into so-called monocyte-derived DCs (moDCs). These DC subsets differ both in ontogeny, localization, and in their functional properties. New identification tools and the availability of transgenic mice targeting specific DC subsets enable the investigation of how these different DC subsets contribute to or suppress asthma pathogenesis. In this review, we will discuss mechanisms used by different DC subsets to elicit or hamper the pathogenesis of both Th2-mediated eosinophilic asthma and more severe Th17-mediated neutrophilic inflammation.

Citing Articles

Oral administration of Limosilactobacillus reuteri VHProbi® M07 alleviates ovalbumin-induced allergic asthma in mice.

Meng G, Cui H, Feng C, Guo C, Song L, Duan Z PLoS One. 2025; 20(1):e0317587.

PMID: 39820222 PMC: 11737801. DOI: 10.1371/journal.pone.0317587.


IL-33 released during challenge phase regulates allergic asthma in an age-dependent way.

Liu H, Wu M, Wang Q, Gao L, Jiang H, Shi K Cell Mol Immunol. 2024; 22(2):191-207.

PMID: 39134801 PMC: 11782506. DOI: 10.1038/s41423-024-01205-2.


TFEB regulates dendritic cell antigen presentation to modulate immune balance in asthma.

Xiang J, Liu B, Li Y, Ren Y, Li Y, Zhou M Respir Res. 2024; 25(1):182.

PMID: 38664707 PMC: 11046778. DOI: 10.1186/s12931-024-02806-1.


Comprehensive analysis of lung macrophages and dendritic cells in two murine models of allergic airway inflammation reveals model- and subset-specific accumulation and phenotypic alterations.

Camp B, Jorde I, Sittel F, Pausder A, Jeron A, Bruder D Front Immunol. 2024; 15:1374670.

PMID: 38529288 PMC: 10961404. DOI: 10.3389/fimmu.2024.1374670.


Catching Our Breath: Updates on the Role of Dendritic Cell Subsets in Asthma.

Lajiness J, Cook-Mills J Adv Biol (Weinh). 2023; 7(6):e2200296.

PMID: 36755197 PMC: 10293089. DOI: 10.1002/adbi.202200296.


References
1.
Lambrecht B, Hammad H . Lung dendritic cells: targets for therapy in allergic disease. Handb Exp Pharmacol. 2008; (188):99-114. DOI: 10.1007/978-3-540-71029-5_5. View

2.
Satpathy A, Briseno C, Lee J, Ng D, Manieri N, Kc W . Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol. 2013; 14(9):937-48. PMC: 3788683. DOI: 10.1038/ni.2679. View

3.
Fear V, Lai S, Zosky G, Perks K, Gorman S, Blank F . A pathogenic role for the integrin CD103 in experimental allergic airways disease. Physiol Rep. 2016; 4(21). PMC: 5112499. DOI: 10.14814/phy2.13021. View

4.
Hammad H, Charbonnier A, Duez C, Jacquet A, Stewart G, Tonnel A . Th2 polarization by Der p 1--pulsed monocyte-derived dendritic cells is due to the allergic status of the donors. Blood. 2001; 98(4):1135-41. DOI: 10.1182/blood.v98.4.1135. View

5.
Hatchwell L, Collison A, Girkin J, Parsons K, Li J, Zhang J . Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax. 2015; 70(9):854-61. PMC: 4552894. DOI: 10.1136/thoraxjnl-2014-205465. View